← Leaderboards
Michael K Lee
Johns Hopkins University
$23,093,996
Attributed
$30,872,515
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,872,515 · 19
By mechanism
R01$20,705,392 · 10
RF1$5,429,349 · 2
R56$1,985,947 · 3
P50$1,979,272 · 2
R21$772,555 · 2
Top collaborators
- Alfonso Araque5 shared
- Dezhi Liao5 shared
- Michael A. Farrar4 shared
- Sylvain E. Lesne2 shared
- Bobby Thomas2 shared
- Darren John Moore1 shared
- Eugenia Trushina1 shared
- Keith Alan Vossel1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ted M. Dawson$31,695,689
- Hanseok Ko$8,865,346
- Kaitlin Stouffer$160,264
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsMouse ModelPathologicIn VivoAlpha SynucleinParkinson DiseaseAttenuatedFunctional DisorderPathogenesisCellsTransgenic MiceMutantNerve DegenerationPathologyAffectLeadBrainNeurodegenerative DisordersExhibitsFuturePathway InteractionsLinkSynuclein
Grant awards (65)
Regulatory T Cells in Alzheimer's Disease$753,422
R01 · FY2025 · AG
Regulation of human tau expression and tauopathy by alpha-synuclein$749,496
R01 · FY2025 · AG · contact PI
Neuroprotective mechanisms of Bach1-Derepression in Alzheimerâs Disease$729,933
R01 · FY2025 · AG
Regulatory T Cells in Alzheimer's Disease$768,798
R01 · FY2024 · AG
Regulation of human tau expression and tauopathy by alpha-synuclein$764,792
R01 · FY2024 · AG · contact PI
Regulatory T Cells in Alzheimer's Disease$768,798
R01 · FY2023 · AG
Regulation of human tau expression and tauopathy by alpha-synuclein$764,792
R01 · FY2023 · AG
Neuroprotective mechanisms of Bach1-Derepression in Alzheimerâs Disease$2,253,614
RF1 · FY2022 · AG
Regulatory T Cells in Alzheimer's Disease$768,798
R01 · FY2022 · AG
Regulation of human tau expression and tauopathy by alpha-synuclein$764,792
R01 · FY2022 · AG
Tau-dependent cognitive deficits in alpha-synucleinopathies$550,840
R01 · FY2022 · NS · contact PI
Alpha-Synuclein Induced Network Hyperexcitability in Lewy Body Dementias$840,282
R56 · FY2021 · AG
Tau-dependent cognitive deficits in alpha-synucleinopathies$550,840
R01 · FY2021 · NS · contact PI
Tau-dependent cognitive deficits in alpha-synucleinopathies$553,561
R01 · FY2020 · NS · contact PI
Pathological role of c-Abl in alpha-synucleinoapathy$446,857
R01 · FY2020 · NS · contact PI
AMP-Kinase as a target for neuroprotection in AD$3,175,735
RF1 · FY2019 · AG · contact PI
Role of alpha-synuclein-dependent network hyperactivity in Lewy Body Dementia$765,665
R56 · FY2019 · NS · contact PI
Tau-dependent cognitive deficits in alpha-synucleinopathies$553,561
R01 · FY2019 · NS · contact PI
Pathological role of c-Abl in alpha-synucleinoapathy$446,857
R01 · FY2019 · NS · contact PI
Tau-dependent cognitive deficits in alpha-synucleinopathies$557,183
R01 · FY2018 · NS · contact PI
Pathological role of c-Abl in alpha-synucleinoapathy$446,132
R01 · FY2018 · NS · contact PI
Unfolded Protein Response in Alpha-synucleinopathies$332,500
R01 · FY2018 · NS · contact PI
Pathological role of c-Abl in alpha-synucleinoapathy$443,230
R01 · FY2017 · NS · contact PI
Unfolded Protein Response in Alpha-synucleinopathies$333,298
R01 · FY2017 · NS · contact PI
Pathological role of c-Abl in alpha-synucleinoapathy$441,054
R01 · FY2016 · NS · contact PI
Unfolded Protein Response in Alpha-synucleinopathies$333,298
R01 · FY2016 · NS · contact PI
Unfolded Protein Response in Alpha-synucleinopathies$338,390
R01 · FY2015 · NS · contact PI
Neurodegenerative interactions in conditional LRRK2 Tg models$310,737
R01 · FY2015 · NS · contact PI
Unfolded Protein Response in Alpha-synucleinopathies$338,387
R01 · FY2014 · NS · contact PI
Neurodegenerative interactions in conditional LRRK2 Tg models$307,630
R01 · FY2014 · NS · contact PI
Neurodegenerative interactions in conditional LRRK2 Tg models$299,861
R01 · FY2013 · NS · contact PI
Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD$278,364
R01 · FY2013 · AG · contact PI
Synucleins: Cell biology and transgenic mice$380,000
R56 · FY2012 · NS · contact PI
Neurodegenerative interactions in conditional LRRK2 Tg models$310,737
R01 · FY2012 · NS · contact PI
Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD$294,565
R01 · FY2012 · AG · contact PI
Neurodegenerative interactions in conditional LRRK2 Tg models$321,894
R01 · FY2011 · NS · contact PI
Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD$294,565
R01 · FY2011 · AG · contact PI
Synucleins: Cell biology and transgenic mice$30,200
R01 · FY2011 · NS · contact PI
Pathological interactions of a-syn, mitochondria, and pesticides in PD models$383,481
R01 · FY2010 · ES · contact PI
Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD$306,455
R01 · FY2010 · AG · contact PI
Pathological interactions of a-syn, mitochondria, and pesticides in PD models$509,357
R01 · FY2009 · ES · contact PI
Synucleins: Cell biology and transgenic mice$359,598
R01 · FY2009 · NS · contact PI
Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD$336,200
R01 · FY2009 · AG · contact PI
Synucleins: Cell biology and transgenic mice$331,093
R01 · FY2009 · NS · contact PI
Synucleins: Cell biology and transgenic mice$359,324
R01 · FY2008 · NS · contact PI
Mechanisms of Neurodegeneration in Human Alpha-Synuclein Transgenic Mice$344,225
P50 · FY2008 · NS · contact PI
Preclinical Evaluation of Celastrol, an Inducer of HSP, in alpha-Syn Tg mice$179,375
R21 · FY2008 · NS · contact PI
Synucleins: Cell biology and transgenic mice$358,228
R01 · FY2007 · NS · contact PI
Mechanisms of Neurodegeneration in Human Alpha-Synuclein Transgenic Mice$344,051
P50 · FY2007 · NS · contact PI
Preclinical Evaluation of Celastrol, an Inducer of HSP, in alpha-Syn Tg mice$215,086
R21 · FY2007 · NS · contact PI
Synucleins: Cell biology and transgenic mice$367,233
R01 · FY2006 · NS · contact PI
Mechanisms of Neurodegeneration in Human Alpha-Synuclein Transgenic Mice$303,552
P50 · FY2006 · NS · contact PI
Synucleins: Cell biology and transgenic mice$374,625
R01 · FY2005 · NS
Mechanisms of Neurodegeneration in Human Alpha-Synuclein Transgenic Mice$294,710
P50 · FY2005 · NS
Conditional Uch-L1 knockout mice$189,047
R21 · FY2005 · NS
Mechanisms of Neurodegeneration in Human Alpha-Synuclein Transgenic Mice$286,130
P50 · FY2004 · NS
Conditional Uch-L1 knockout mice$189,047
R21 · FY2004 · NS
SYNUCLEINS--CELL BIOLOGY AND TRANSGENIC MICE$349,223
R01 · FY2002 · NS
BIOLOGY OF ALPHA-SYNUCLEIN IN PARKINSON'S DISEASE$88,647
P50 · FY2002 · NS
SYNUCLEINS--CELL BIOLOGY AND TRANSGENIC MICE$340,808
R01 · FY2001 · NS
BIOLOGY OF ALPHA-SYNUCLEIN IN PARKINSON'S DISEASE$88,647
P50 · FY2001 · NS
SYNUCLEINS--CELL BIOLOGY AND TRANSGENIC MICE$50,000
R01 · FY2001 · NS
BIOLOGY OF ALPHA-SYNUCLEIN IN PARKINSON'S DISEASE$0
P50 · FY2001 · NS
SYNUCLEINS--CELL BIOLOGY AND TRANSGENIC MICE$331,605
R01 · FY2000 · NS
BIOLOGY OF ALPHA-SYNUCLEIN IN PARKINSON'S DISEASE$229,310
P50 · FY2000 · NS